SONENDO INC - SONX STOCK NEWS

Sonendo, a leading dental technology company, reported its financial results for Q4 and the full year 2021. Total revenue for Q4 reached $9.9 million, a 14% increase year-over-year, and $33.2 million for the entire year, marking a 42% growth from 2020. The company achieved a gross margin of 25% in Q4, up from 20% in Q4 2020. Despite a net loss of $13.7 million in Q4, the company raised $84 million during its IPO. For 2022, Sonendo expects to generate between $40 million and $43 million in revenue.

Sonendo, Inc. (NYSE: SONX) has reached a significant milestone of 800,000 GentleWave patient procedures, just five months after hitting 700,000. This achievement indicates increasing adoption of the GentleWave System, a less invasive and less painful alternative to traditional root canal therapy. The milestone was celebrated by Dr. Mark Germack, who treated the 800,000th patient. Additionally, Sonendo announced investment in Area Practice Consultants to aid onboarding and practice growth for endodontists, reflecting the company's commitment to improving treatment efficacy and customer support.

Sonendo, Inc. (NYSE: SONX), a dental technology firm, will report its financial results for Q4 and the full year 2021 after market close on March 23, 2022. A conference call will follow at 1:30 PM PT / 4:30 PM ET to discuss these results. Investors can access the call by dialing (844) 200-6205 for domestic or (929) 526-1599 for international listeners, using access code: 450135. Live audio webcasts will also be available on the company's investor website.

Sonendo, Inc. (NYSE: SONX) announced preliminary revenue results for Q4 and full-year 2021. For Q4, revenue is estimated between $9.7 million and $9.9 million, with product revenue expected between $7.5 million and $7.7 million. Full-year revenue is anticipated to be $33.0 million to $33.2 million, marking a growth of 41% to 42% compared to $23.4 million in 2020. Sonendo highlights the effective expansion of its commercial team and the growing adoption of its GentleWave® System as key achievements.

Sonendo, a leading dental technology firm, reported a 29% increase in total revenue for Q3 2021, totaling $7.9 million.

The GentleWave console revenue rose 44% to $1.8 million, while procedure instrument revenue climbed 30% to $3.7 million. Software revenue grew 17% to $1.7 million. The company completed its IPO on November 2, raising approximately $84 million.

For 2021, Sonendo projects total revenue between $32 million and $32.5 million.

Sonendo (NYSE: SONX) has appointed Raj Pudipeddi to its Board of Directors. Pudipeddi, currently an executive at Align Technology, brings 27 years of experience in brand-building and consumer products. His background includes leadership roles at Procter & Gamble and Bharti Airtel. Sonendo's president and CEO, Bjarne Bergheim, highlighted Pudipeddi's expertise in driving growth and innovation in transforming root canal therapy through the GentleWave System. This addition follows the recent announcement of three other new board members.

Sonendo, a dental technology leader, will release its third-quarter financial results after market close on December 9, 2021. A conference call will be held at 1:30 p.m. PT to discuss these results. The company is known for its GentleWave System, which enhances root canal treatments by effectively cleaning and disinfecting teeth, reducing post-operative discomfort, and improving clinical outcomes. Sonendo also owns TDO Software, which streamlines dental practice management.

Sonendo, Inc. (NYSE: SONX) has appointed Alma Salazar as the Associate Vice President of Professional and Consumer Marketing. Salazar brings extensive experience from Align Technology, where she led successful marketing campaigns. With approximately 17 million root canal procedures performed annually in the U.S. and Canada, Sonendo aims to enhance patient education about its GentleWave® System, which offers innovative alternatives to traditional methods. Salazar's expertise is expected to help Sonendo strengthen its market presence and improve patient outcomes.

Sonendo, Inc. (NYSE: SONX) has successfully treated over 700,000 patients using its innovative GentleWave^® System, marking a significant milestone shortly after its IPO on October 29, 2021. The GentleWave System offers a less invasive alternative to traditional root canal therapy, utilizing advanced technology to enhance cleaning and disinfection within teeth while preserving tooth structure. Clinical outcomes are notably improved, with rapid healing rates and minimal post-operative pain reported. This achievement underscores the company's commitment to enhancing dental care.